| Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England journal of medicine 361 (12), 1139-1151, 2009 | 14861 | 2009 |
| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 13353 | 2021 |
| Apixaban versus warfarin in patients with atrial fibrillation CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ... New England Journal of Medicine 365 (11), 981-992, 2011 | 11357 | 2011 |
| ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology … Developed in Collaboration With the European Heart Rhythm Association and ... Journal of the American College of Cardiology 48 (5), e247-e346, 2006 | 4771 | 2006 |
| Alirocumab and cardiovascular outcomes after acute coronary syndrome GG Schwartz, PG Steg, M Szarek, DL Bhatt, VA Bittner, R Diaz, ... New England Journal of Medicine 379 (22), 2097-2107, 2018 | 3484 | 2018 |
| Apixaban in patients with atrial fibrillation SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ... New England Journal of Medicine 364 (9), 806-817, 2011 | 3454 | 2011 |
| Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology A Vahanian, H Baumgartner, J Bax, E Butchart, R Dion, G Filippatos, ... European heart journal 28 (2), 230-268, 2007 | 2922 | 2007 |
| Spironolactone for heart failure with preserved ejection fraction B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ... New England Journal of Medicine 370 (15), 1383-1392, 2014 | 2911 | 2014 |
| Acc/aha/esc 2006 guidelines for the management of patients with atrial fibrillation: A report of the american college of cardiology/american heart association task force on … V Fuster, LE Rydén, DS Cannom, HJ Crijns, AB Curtis, KA Ellenbogen, ... Circulation 114 (7), e257-e354, 2006 | 2871* | 2006 |
| Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised … PA Poole-Wilson, K Swedberg, JGF Cleland, A Di Lenarda, P Hanrath, ... The Lancet 362 (9377), 7-13, 2003 | 2762 | 2003 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2712 | 2019 |
| Lixisenatide in patients with type 2 diabetes and acute coronary syndrome MA Pfeffer, B Claggett, R Diaz, K Dickstein, HC Gerstein, LV Køber, ... New England Journal of Medicine 373 (23), 2247-2257, 2015 | 2706 | 2015 |
| Rivaroxaban with or without aspirin in stable cardiovascular disease JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ... New England Journal of Medicine 377 (14), 1319-1330, 2017 | 2649 | 2017 |
| Efficacy and safety of low-dose colchicine after myocardial infarction JC Tardif, S Kouz, DD Waters, OF Bertrand, R Diaz, AP Maggioni, FJ Pinto, ... New England journal of medicine 381 (26), 2497-2505, 2019 | 2608 | 2019 |
| Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study MJ O'Donnell, SL Chin, S Rangarajan, D Xavier, L Liu, H Zhang, ... The lancet 388 (10046), 761-775, 2016 | 2490 | 2016 |
| 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of … V Fuster, LE Rydén, DS Cannom, HJ Crijns, AB Curtis, KA Ellenbogen, ... Journal of the American College of Cardiology 57 (11), e101-e198, 2011 | 2423* | 2011 |
| Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries CK Chow, KK Teo, S Rangarajan, S Islam, R Gupta, A Avezum, ... Jama 310 (9), 959-968, 2013 | 2357 | 2013 |
| Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) RM Inciardi, L Lupi, G Zaccone, L Italia, M Raffo, D Tomasoni, DS Cani, ... JAMA cardiology 5 (7), 819-824, 2020 | 2326 | 2020 |
| † Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text‡: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology … L Ryden, E Standl, M Bartnik, GV Berghe, J Betteridge, MJ De Boer, ... European heart journal supplements 9 (suppl_C), C3-C74, 2007 | 2248 | 2007 |
| Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy GM Felker, RE Thompson, JM Hare, RH Hruban, DE Clemetson, ... New England Journal of Medicine 342 (15), 1077-1084, 2000 | 2231 | 2000 |
